CEO SUMMARY: When Neuromedical Systems entered Chapter 11 bankruptcy, AutoCyte moved rapidly to purchase Neuromedical’s patents and other intellectual property for automated cytology technology. Even as Neuromedical disappears from the marketplace, AutoCyte is preparing its entry. Laboratories will soon have a new brand of automated cytology technology to evaluate for purchase. EXECUTIVES AT AUTOCYTE, INC. […]
AutoCyte to Buy NSI’s Patents and Other Assets
FDA gives favorable review to firm’s data on its Pap smear PREP® system
- By Robert Michel
- > From the Volume VI No. 5 - April 5, 1999 Issue
